CAS: 595566-61-3 - Pagibaximab
Formula:Unspecified
- Synonyms:
- A 110
- Immunoglobulin G1, anti-(Staphylococcus epidermidis lipoteichoic acid) (human-mouse monoclonal heavy chain), disulfide with human-mouse monoclonal κ-chain, dimer
- BSYX-A 110
- Pagibaximab
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Pagibaximab REF: TM-T76822CAS: 595566-61-3 | - - - | To inquire | Fri 25 Oct 24 |
 | Pagibaximab REF: 3D-CLA1193CAS: 595566-61-3 | - - - | To inquire | Mon 04 Nov 24 |
Pagibaximab
CAS:595566-61-3
Pagibaximab, a chimeric IgG1, targets lipoteichoic acid to prevent staph sepsis from S. aureus/epidermidis.
Color and Shape:
Solid
Molecular weight:
146.07 (kDa)
Ref: TM-T76822
| 5mg | To inquire |
Estimated delivery in United States, on Friday 25 Oct 2024
Pagibaximab
CAS:595566-61-3
Chimeric monoclonal antibody targeting staphylococcal lipoteichoic acid; prevents staphylococcal sepsis in infants
Ref: 3D-CLA1193
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 4 Nov 2024
